P19-03. Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12 by Wilson IA, Dwek RA, Wormald MR, Scanlan CN, Doores KJ, Fulton Z, Davis BG

P12-06. A 'non-self' mimic of the natural epitope of anti-HIV antibody 2G12 shows enhanced antigenicity by Burton DR, Wilson IA, Dwek RA, Wormald MR, Scanlan CN, Fulton Z, Doores KJ, Davis BG

Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization by Zeltina, A, Krumm, SA, Sahin, M, Struwe, WB, Harlos, K, Nunberg, JH, Crispin, M, Pinschewer, DD, Doores, KJ, Bowden, TA

Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2 by Dicks, MDJ, Rose, LM, Russell, RA, Bowman, LAH, Graham, C, Jimenez-Guardeño, JM, Doores, KJ, Malim, MH, Draper, SJ, Howarth, M, Biswas, S

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies by Julien J, Kong L, Pejchal R, Khayat R, Lee J, Stanfield RS, Walker LM, Doores KJ, Folkowska E, Poignard P, Depetris R, Sanders RW, Koff WC, Moore JP, Ward AB, Burton DR, Wilson IA

A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus by Allen, ER, Krumm, SA, Raghwani, J, Halldorsson, S, Elliott, A, Graham, VA, Koudriakova, E, Harlos, K, Wright, D, Warimwe, GM, Brennan, B, Huiskonen, JT, Dowall, SD, Elliott, RM, Pybus, OG, Burton, DR, Hewson, R, Doores, KJ, Bowden, TA